Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial
Authors:
- Indian Polycap Study (TIPS)I(Indian Polycap Study (TIPS)
- S YusufSYS Yusuf
- P PaisPPP Pais
- R AfzalRAR Afzal
- D XavierDXD Xavier
- K TeoKTK Teo
- J EikelboomJEJ Eikelboom
- A SigamaniASA Sigamani
- V MohanVMV Mohan
- R GuptaRGR Gupta
- N ThomasNTN Thomas
Top Cited Papers
- 1 April 2009
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 373 (9672) , 1341-1351
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The need to test the theories behind the Polypill: rationale behind the Indian Polycap StudyNature Clinical Practice Cardiovascular Medicine, 2008
- Homocysteine Lowering with Folic Acid and B Vitamins in Vascular DiseaseNew England Journal of Medicine, 2006
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ, 2003
- Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trialsBMJ, 2003
- A strategy to reduce cardiovascular disease by more than 80%BMJ, 2003
- Two decades of progress in preventing vascular diseaseThe Lancet, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985